Shkreli: AI Labs Should Partner with PE to Acquire Enterprise Data
Martin Shkreli · Weekly Recap: CEO Affair at Coldplay Concert, Elon Musk's AI Girlfriend, Cognition Acquires Windsurf · Jul 19, 2025 · at 2:29:23
Martin Shkreli proposes a strategy for frontier artificial intelligence companies to access proprietary legacy enterprise codebases and domain data through leveraged buyouts.
0:00 / 0:28exact quote · 28.2s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“I sometimes joke that the big AI companies should become LBO shops. And what they can do is they can partner with KKR or Blackstone and all they get is the data. KKR and Blackstone pride the capital, get all the returns. Fine. But all the data comes back to, you know, the open AI's or whoever. And by getting the old code bases out of a McDonald's or out of a Walmart that You know, some of the quotas written in the 19 seventies, you know, they have unique data that nobody else has.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Martin Shkreli
Shkreli: BPC-157 is a scam with zero therapeutic value
“BPC-one-five-seven is the biggest scam I've ever seen. It does absolutely nothing. There's no redeemable value to this.”
Jane Street, Millennium, Citadel bid on Aschenbrenner's liquidated fund assets
“Interestingly, we heard that three firms were bidding on the assets. So Jane Street, Millennium and Citadel were sort of brought in in a closed Close circle sort of late Friday to bid on the remains of the firm.”
Shkreli: Aschenbrenner shopped Anthropic stake at $1.1T valuation for liquidity
“And the rumor is over the weekend, he contacted about 10 parties to place Anthropic in an effort to shore up liquidity, selling the Anthropic stake for allegedly the offer was at a 1.1 trillion equivalent market cap which, you know, I think roughly where it's …”
Shkreli: Peptide craze is driven by psychological issues and institutional distrust
“I'm very concerned about the peptide craze. I think it comes mostly out of psychological issues which we'll discuss. The need for identity, control distrust of institutions, all kinds of things like that are leading to what we're seeing today.”
Shkreli: No clinical trial of BPC-157 will ever work
“I would bet anything. I would bet anything. No trial of BPC would work.”
Shkreli: Mike Bloomberg could be worth $400B-$500B via private equity
“He's taken the Bloomberg dividends and pumped it into a family office that basically Carlisle and all these guys, you know, the Warburg Pincus, all the private equity guys like KKR, They go to him first, and he tosses in, like, five hundred million in each of …”